The goal of treating Von Willebrand Disease (VWD) is to replace deficient or dysfunctional Von Willebrand Factor (VWF) protein. However, the choice of treatment has to be considered carefully in view of patient factors and the unique properties of replacement products. Tailoring a treatment plan to an individual patient's bleeding challenge is an intricate process. This review describes personalization of treatment selection for desmopressin (DDAVP), VWF replacement concentrates, including the newly available recombinant VWF (rVWF) and prophylaxis as a treatment approach in VWD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transci.2019.08.009 | DOI Listing |
Publication Analysis
Top Keywords
von willebrand
8
personalized approach
4
approach management
4
management vwd
4
vwd goal
4
goal treating
4
treating von
4
willebrand disease
4
disease vwd
4
vwd replace
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!